Blend Labs Q2 Sales $32.10M May Not Compare To $93.01M Estimate
Blend Labs (NYSE:BLND) reported quarterly sales of $32.10 million which missed the analyst consensus estimate of $93.01 million by 65.49 percent.
Earnings Scheduled For August 19, 2021
Companies Reporting Before The Bell
• Bilibili (NASDAQ:BILI) is likely to report quarterly loss at $2.86 per share on revenue of $658.78 million.
UBS Initiates Coverage On Blend Labs with Neutral Rating, Announces Price Target of $20
UBS analyst Karl Keirstead initiates coverage on Blend Labs (NYSE:BLND) with a Neutral rating and announces Price Target of $20.
Wells Fargo Initiates Coverage On Blend Labs with Overweight Rating, Announces Price Target of $24
Wells Fargo analyst Michael Turrin initiates coverage on Blend Labs (NYSE:BLND) with a Overweight rating and announces Price Target of $24.
William Blair Initiates Coverage On Blend Labs with Outperform Rating
William Blair analyst Bhavan Suri initiates coverage on Blend Labs (NYSE:BLND) with a Outperform rating.
Canaccord Genuity Initiates Coverage On Blend Labs with Buy Rating, Announces Price Target of $28
Canaccord Genuity analyst Joseph Vafi initiates coverage on Blend Labs (NYSE:BLND) with a Buy rating and announces Price Target of $28.
Truist Securities Initiates Coverage On Blend Labs with Buy Rating, Announces Price Target of $24
Truist Securities initiates coverage on Blend Labs (NYSE:BLND) with a Buy rating and announces Price Target of $24.
Goldman Sachs Initiates Coverage On Blend Labs with Buy Rating, Announces Price Target of $30
Goldman Sachs analyst Michael Ng initiates coverage on Blend Labs (NYSE:BLND) with a Buy rating and announces Price Target of $30.
Keybanc Initiates Coverage On Blend Labs with Overweight Rating, Announces Price Target of $25
Keybanc analyst Josh Beck initiates coverage on Blend Labs (NYSE:BLND) with a Overweight rating and announces Price Target of $25.